**Supreme Court Flags 10-Fold Markup on Cancer Medicine**

The Supreme Court questioned how an essential cancer medicine could carry an MRP of ₹27,000 despite being sold to retailers for ₹2,700. 

The court also noted that such costs can ultimately burden taxpayers when medicines are reimbursed under government health schemes, raising concerns over pricing and possible irregularities.